Literature DB >> 494284

The use of urinary N-acetyl-beta-glucosaminidase in human renal toxicology. II. Elevation in human excretion after aspirin and sodium salicylate.

T D Lockwood, H B Bosmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 494284     DOI: 10.1016/0041-008x(79)90258-8

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  7 in total

1.  Systemic levels of free 5-aminosalicylic acid depend on the nature of the 5-aminosalicyclic acid derivative and not on disease activity or extent in patients with inflammatory bowel disease.

Authors:  N Mahmud; D G Weir; D Kelleher
Journal:  Ir J Med Sci       Date:  1999 Oct-Dec       Impact factor: 1.568

2.  Elevation of urinary N-acetyl-beta-D-glucosaminidase and beta-galactosidase activities in workers with long-term exposure to aromatic nitro-amino compounds.

Authors:  M Yoshida; M Sunaga; I Hara; M Katsumata; M Minami
Journal:  Bull Environ Contam Toxicol       Date:  1989-07       Impact factor: 2.151

3.  Evaluation of urinary elimination of N-acetyl-beta-glucosaminidase in healthy volunteers treated with dibekacin or gentamicin.

Authors:  J Camí; J Segura; J E Baños; I Garcia; L Drobnic
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

4.  Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate.

Authors:  S Schreiber; J Hämling; E Zehnter; S Howaldt; W Daerr; A Raedler; W Kruis
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

5.  Progressive renal insufficiency in methylmalonic acidemia.

Authors:  K H Molteni; T D Oberley; J A Wolff; A L Friedman
Journal:  Pediatr Nephrol       Date:  1991-05       Impact factor: 3.714

6.  Tests of renal function in patients with quiescent colitis: effects of drug treatment.

Authors:  S A Riley; D R Lloyd; V Mani
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

7.  Effects of prochlorperazine on experimental nephrotoxicity.

Authors:  S D Harrison; J L Cox; R C Giles
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.